Code | 3273D | ||||||||||
MA number | EU/1/19/1392/001 | ||||||||||
Product Form: | sol inj 10x1 ml (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Merck Sharp & Dohme B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 14.01.2021 |
Validity: | 14.01.2026 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 26.11.2021 |